OpenURL Connection Search

Select item for more details and to access through your institution.

Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD.
Published in:
Journal of Medical Virology, 2023, v. 95, n. 6, p. 1, doi. 10.1002/jmv.28875
By:
- Tragni, Vincenzo;
- Mercurio, Ivan;
- Paoletti, Diletta Pia;
- Onofrio, Angelo;
- Laera, Luna;
- Cafferati Beltrame, Lucas;
- Sgobba, Maria Noemi;
- Guerra, Lorenzo;
- Volpicella, Mariateresa;
- De Grassi, Anna;
- Elia, Gabriella;
- Pierri, Ciro Leonardo
Publication type:
Article
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
Published in:
Cellular & Molecular Life Sciences, 2021, v. 78, n. 4, p. 1501, doi. 10.1007/s00018-020-03580-1
By:
- Mercurio, Ivan;
- Tragni, Vincenzo;
- Busto, Francesco;
- De Grassi, Anna;
- Pierri, Ciro Leonardo
Publication type:
Article
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39662-w
By:
- Abatematteo, Francesca Serena;
- Delre, Pietro;
- Mercurio, Ivan;
- Rezelj, Veronica V.;
- Siliqi, Dritan;
- Beaucourt, Stephanie;
- Lattanzi, Gianluca;
- Colabufo, Nicola Antonio;
- Leopoldo, Marcello;
- Saviano, Michele;
- Vignuzzi, Marco;
- Mangiatordi, Giuseppe Felice;
- Abate, Carmen
Publication type:
Article

Found: 3

Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD.

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.

A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach.